Effects of dopaminergic agents on reversal of reserpine-induced impairment in conditioned avoidance response in rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 4, 1997, Pages 829-836

  Nakagawa, Terutake ^a   Ukai, Kiyoharu ^a   Ohyama, Tadashi ^a   Gomita, Yutaka ^b   Okamura, Hitoshi ^c  

^a KAKEN PHARMACEUTICAL CO LTD   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antidepressive agents; Calcium channel antagonists; D1 and D2 interaction; DAergic agonists; Monoamine uptake inhibitor; Shuttle box

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 5 HYDROXYTRYPTOPHAN; AMANTADINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; APOMORPHINE; ATROPINE; CALCIUM CHANNEL BLOCKING AGENT; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESIPRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOSULEPIN; FLUNARIZINE; IMIPRAMINE; INDELOXAZINE; METHAMPHETAMINE; NIMODIPINE; NOMIFENSINE; QUINPIROLE; RESERPINE; SIBUTRAMINE; THREO 3,4 DIHYDROXYPHENYLSERINE;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; FORCED SWIMMING TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031406439     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)98984-X     Document Type: Article

References (33)

1. Ahlenius S. Effects of 1-dopa on conditioned avoidance responding after behavioural suppression by alfa-methyltyrosine or reserpine in mice. Neuropharmacology. 13:1974;729-739.
2. Arnt J., Hyttel J., Peregaard J. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur. J. Pharmacol. 133:1987;137-145.
3. Beninger R. J. The role of dopamine in locomotion activity and learning. Brain Res. Brain Res. Rev. 6:1983;173-196.
4. Bourin M., Poncelet M., Chermat R., Simon P. The value of the reserpine test in psychopharmacology. Arzneimittelforschung. 33:1983;1173-1176.
5. Bourin M. Is it possible to predict the activity of a new antidepressive agent in animals with simple psychopharmacological test? Fundam. Clin. Pharmacol. 4:1990;49-64.
6. Bracs P. U., Jackson D. M., Gregory P. α-Methyl-p-tyrosine inhibition of a conditioned avoidance response. Psychopharmacology (Berlin). 77:1982;159-163.
7. Canning H., Goff D., Leach M. J., Miller A. A., Tateson J. E., Wheatley P. L. The involvement of dopamine in the central actions of bupropion, a new antidepressive agent. Br. J. Pharmacol. 66:1979;104P-105P.
8. Colpaert F. C. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmcology. 26:1987;1431-1440.
9. Costa E., Garattini S., Valezelli L. Interacions between reserpine, chlorpromazine and imipramine. Experientia. 16:1960;461-463.
10. Dismukes R. K., Rake A. V. Involvement of biogenic amines in memory formation. Psychopharmacologia. 23:1972;17-25.
11. Fuller R. W. Enhancement of monoaminergic Neurotransmission by antidepressant drugs. Enna S. J., Malick J. B., Richelson E. Antidepressants. Neurochemical, behavioral, and clinical perspectives:1981;1-12 Raven Press, New York.
12. Geoffroy M., Morgensen J. Differential recovery in measures of exploration/locomotion after a single dosage of reserpine in the rat. Acta Neurobiol. Exp[. (Warsz). 48:1988;263-274.
13. Hirate K., Kuribara H., Tadokoro S. Breeder differences within Wistar strain rats in acquisition of discrete shuttle avoidance response and in sensitivity to chlorpromazine. Jpn. J. Pharmacol. 47:1988;209-216.
14. Hirate K., Kuribara H., Tadokoro S. Breeder differences within Wistar strain rats in step-through type passive avoidance response. Jpn. J. Pharmacol. 51:1989;563-567.
15. Hunt P., Kannengiesser M. H., Raynaud J. P. Nomifensine. A new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum J. Pharm. Pharmacol. 26:1974;370-371.
16. Iorio L. C., Cohen M., Coffin V. L. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats. J. Pharmacol. Exp. Ther. 258:1991;118-123.
17. Kuribara H. Strain differences to the effects of central acting drugs on sidman avoidance response in Wistar and Fisher 344 rats. Pharmacol. Biochem. Behav. 17:1982;425-429.
18. Nakagawa T., Ukai K., Kubo S., Masuda C., Ase K., Nakanishi M. Effects of KP-840 on the forced swimming test in mice. Jpn. J. Pharmacol. 55(Suppl. I):1991;207P.
19. Nakagawa T., Ukai K., Kubo S. Antidepressive effects of the stereoisomer cis-dosulepin hydrochloride. Arzneimittelforschung. 43:1993;11-15.
20. Nakagawa T., Ukai K., Doi K., Fuji K. Studies of EEG on resrpine induced amnesia in rats. Jpn. J. Psychopharmacol. 13:1993;505.
21. Nakagawa T., Ukai K., Ohyama T., Koida M. Quantitative analysis of pharmacoelectroencephalogram usig MemCalc system, composed of combination of the maximum entropy method and the non-linear least squares method. Saito K., Koyama A., Yoneyama K., Sawada Y., Ohtomo N. A recent advance in time series analysis by maximum entropy method. 1995;369-382 Hokkaido University Press, Applications to medical and biological sciences. Hokkaido.
22. Nakamura C. Y., Anderson N. H. Avoidance behavior differences within and between strains of rats. J. Comp. Phsyiol. Psychol. 55:1962;740-747.
23. Pavlides C., Greenstein Y. J., Grudman M., Winson J. Long-term potentiation in the dentate gyrus is induced preferentially on the positive phase of theta-rhythm. Brain Res. 439:1988;383-387.
24. Ponzio F., Achilli G., Calderini G., Ferretti P., Perego C., Toffano G., Algeri A. Depletion and recovery of neuronal monoamine storage in rats of different ages treated with reserpine. Neurobiol. Aging. 5:1984;101-104.
25. Quartermain D., Judge M. Recovery of memory following forgetting induced by depletion of biogenic amines. Pharmacol. Biochem. Behav. 18:1983;179-184.
26. Rouillard C., Bedard P. J. Specific D1 and D2 dopamine agonists have syndergistic effects in the 6-hydroxydopamine circling behavior model in the rat. Neuropharmacology. 27:1988;1257-1264.
27. Seeman P., Van Tol H. H. M. Dopamine receptor pharmacology. Trends Pharmacol Sci. 15:1994;264-270.
28. Seiden L. S., Carlsson A. Temporary and partial antagonism by L-DOPA of reserpine-induced supression of a conditioned avoidance response. Psychopharmacologia. 4:1963;418-423.
29. Seiden L. S., Hanson L. C. F. Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cats by L-DOPA. Psychopharmacologia. 6:1964;239-244.
30. Simon H., Scatton B., Moal M. L. Dopaminergic A10 neurones are involved in conitive functions. Nature. 286:1980;150-151.
31. Taguchi G. System of experimental design, vol. 1. New York:1987;239-269. American Supplier Institute;
32. Willner P. Animal models as simulations of depression. Trends Pharamcol. Sci. 12:1991;131-136.
33. Yamada J., Nikaido H., Matsumoto S. Genetic variability within and between outbred Wistar strains of rats. Jikken Doubutsu. 28:1979;259-265.